AllovirInc Common Stock Shares Outstanding vs Net Receivables Analysis

ALVR Stock

USD 0.79 0.02 2.60%

AllovirInc financial indicator trend analysis is way more than just evaluating AllovirInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AllovirInc is a good investment. Please check the relationship between AllovirInc Common Stock Shares Outstanding and its Net Receivables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AllovirInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.

Common Stock Shares Outstanding vs Net Receivables

Common Stock Shares Outstanding vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AllovirInc Common Stock Shares Outstanding account and Net Receivables. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between AllovirInc's Common Stock Shares Outstanding and Net Receivables is -0.38. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Net Receivables in the same time period over historical financial statements of AllovirInc, assuming nothing else is changed. The correlation between historical values of AllovirInc's Common Stock Shares Outstanding and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of AllovirInc are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Common Stock Shares Outstanding i.e., AllovirInc's Common Stock Shares Outstanding and Net Receivables go up and down completely randomly.

Correlation Coefficient

-0.38

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Net Receivables

Most indicators from AllovirInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AllovirInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AllovirInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.At this time, AllovirInc's Issuance Of Capital Stock is relatively stable compared to the past year. As of 05/21/2024, Sales General And Administrative To Revenue is likely to grow to 60.81, while Selling General Administrative is likely to drop slightly above 33.9 M.

	2021	2022	2023	2024 (projected)
Interest Income	1.3M	1.9M	5.3M	5.5M
Net Interest Income	1.3M	1.9M	5.3M	5.5M

Interest Income Net Interest Income

AllovirInc fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Long Term Debt Total	Property Plant And Equipment Net
Total Assets		0.84	0.79	0.96	0.94	-0.33	-0.87	-0.65	0.65	0.91	0.72	0.52	0.59	1.0	-0.19	0.48	-0.35	-0.92	0.89	0.69	-0.11	0.96	1.0	0.99	0.61	0.27
Other Current Liab	0.84		0.97	0.79	0.79	-0.33	-0.91	-0.72	0.91	0.97	0.85	0.16	0.77	0.81	-0.57	0.65	-0.33	-0.81	0.84	0.8	-0.03	0.79	0.82	0.78	0.85	0.5
Total Current Liabilities	0.79	0.97		0.75	0.79	-0.42	-0.84	-0.82	0.97	0.92	0.76	0.06	0.68	0.77	-0.63	0.77	-0.37	-0.79	0.81	0.87	-0.07	0.75	0.77	0.72	0.89	0.39
Total Stockholder Equity	0.96	0.79	0.75		0.98	-0.3	-0.84	-0.64	0.63	0.86	0.64	0.36	0.51	0.96	-0.32	0.38	-0.59	-0.79	0.89	0.7	-0.38	1.0	0.96	0.96	0.59	0.26
Net Tangible Assets	0.94	0.79	0.79	0.98		-0.36	-0.81	-0.72	0.7	0.84	0.59	0.32	0.46	0.94	-0.34	0.5	-0.6	-0.8	0.86	0.76	-0.38	0.98	0.94	0.93	0.62	0.17
Current Deferred Revenue	-0.33	-0.33	-0.42	-0.3	-0.36		0.14	0.78	-0.44	-0.31	0.11	0.15	0.09	-0.34	0.23	-0.56	0.32	0.43	-0.29	-0.72	0.09	-0.3	-0.34	-0.32	-0.43	0.51
Net Debt	-0.87	-0.91	-0.84	-0.84	-0.81	0.14		0.48	-0.78	-0.98	-0.77	-0.38	-0.89	-0.86	0.38	-0.37	0.33	0.76	-0.73	-0.56	0.09	-0.84	-0.86	-0.84	-0.58	-0.46
Retained Earnings	-0.65	-0.72	-0.82	-0.64	-0.72	0.78	0.48		-0.78	-0.64	-0.42	0.1	-0.17	-0.64	0.52	-0.87	0.44	0.72	-0.74	-0.98	0.16	-0.64	-0.65	-0.61	-0.85	0.03
Accounts Payable	0.65	0.91	0.97	0.63	0.7	-0.44	-0.78	-0.78		0.85	0.63	-0.06	0.68	0.63	-0.67	0.77	-0.39	-0.67	0.65	0.83	-0.1	0.63	0.64	0.58	0.83	0.28
Cash	0.91	0.97	0.92	0.86	0.84	-0.31	-0.98	-0.64	0.85		0.8	0.32	0.82	0.89	-0.44	0.52	-0.35	-0.84	0.81	0.72	-0.07	0.86	0.89	0.87	0.71	0.42
Non Current Assets Total	0.72	0.85	0.76	0.64	0.59	0.11	-0.77	-0.42	0.63	0.8		0.24	0.7	0.67	-0.44	0.46	-0.09	-0.67	0.83	0.51	0.12	0.64	0.67	0.65	0.75	0.83
Non Currrent Assets Other	0.52	0.16	0.06	0.36	0.32	0.15	-0.38	0.1	-0.06	0.32	0.24		0.34	0.54	0.69	-0.02	0.42	-0.59	0.2	-0.16	0.46	0.36	0.54	0.57	-0.22	-0.05
Other Assets	0.59	0.77	0.68	0.51	0.46	0.09	-0.89	-0.17	0.68	0.82	0.7	0.34		0.57	-0.31	0.21	-0.03	-0.54	0.41	0.26	0.16	0.51	0.56	0.54	0.39	0.53
Cash And Short Term Investments	1.0	0.81	0.77	0.96	0.94	-0.34	-0.86	-0.64	0.63	0.89	0.67	0.54	0.57		-0.15	0.46	-0.36	-0.92	0.86	0.67	-0.12	0.96	1.0	1.0	0.56	0.22
Net Receivables	-0.19	-0.57	-0.63	-0.32	-0.34	0.23	0.38	0.52	-0.67	-0.44	-0.44	0.69	-0.31	-0.15		-0.38	0.66	0.05	-0.45	-0.64	0.51	-0.32	-0.16	-0.11	-0.74	-0.47
Common Stock Shares Outstanding	0.48	0.65	0.77	0.38	0.5	-0.56	-0.37	-0.87	0.77	0.52	0.46	-0.02	0.21	0.46	-0.38		-0.05	-0.69	0.58	0.81	0.22	0.38	0.46	0.42	0.82	0.06
Non Current Liabilities Total	-0.35	-0.33	-0.37	-0.59	-0.6	0.32	0.33	0.44	-0.39	-0.35	-0.09	0.42	-0.03	-0.36	0.66	-0.05		0.05	-0.44	-0.55	0.94	-0.59	-0.36	-0.35	-0.37	-0.03
Inventory	-0.92	-0.81	-0.79	-0.79	-0.8	0.43	0.76	0.72	-0.67	-0.84	-0.67	-0.59	-0.54	-0.92	0.05	-0.69	0.05		-0.79	-0.69	-0.23	-0.79	-0.91	-0.9	-0.62	-0.15
Other Current Assets	0.89	0.84	0.81	0.89	0.86	-0.29	-0.73	-0.74	0.65	0.81	0.83	0.2	0.41	0.86	-0.45	0.58	-0.44	-0.79		0.8	-0.2	0.89	0.87	0.85	0.82	0.5
Other Stockholder Equity	0.69	0.8	0.87	0.7	0.76	-0.72	-0.56	-0.98	0.83	0.72	0.51	-0.16	0.26	0.67	-0.64	0.81	-0.55	-0.69	0.8		-0.26	0.7	0.68	0.64	0.9	0.11
Total Liab	-0.11	-0.03	-0.07	-0.38	-0.38	0.09	0.09	0.16	-0.1	-0.07	0.12	0.46	0.16	-0.12	0.51	0.22	0.94	-0.23	-0.2	-0.26		-0.38	-0.13	-0.13	-0.1	0.03
Net Invested Capital	0.96	0.79	0.75	1.0	0.98	-0.3	-0.84	-0.64	0.63	0.86	0.64	0.36	0.51	0.96	-0.32	0.38	-0.59	-0.79	0.89	0.7	-0.38		0.96	0.96	0.59	0.26
Total Current Assets	1.0	0.82	0.77	0.96	0.94	-0.34	-0.86	-0.65	0.64	0.89	0.67	0.54	0.56	1.0	-0.16	0.46	-0.36	-0.91	0.87	0.68	-0.13	0.96		1.0	0.57	0.22
Net Working Capital	0.99	0.78	0.72	0.96	0.93	-0.32	-0.84	-0.61	0.58	0.87	0.65	0.57	0.54	1.0	-0.11	0.42	-0.35	-0.9	0.85	0.64	-0.13	0.96	1.0		0.52	0.2
Short Long Term Debt Total	0.61	0.85	0.89	0.59	0.62	-0.43	-0.58	-0.85	0.83	0.71	0.75	-0.22	0.39	0.56	-0.74	0.82	-0.37	-0.62	0.82	0.9	-0.1	0.59	0.57	0.52		0.48
Property Plant And Equipment Net	0.27	0.5	0.39	0.26	0.17	0.51	-0.46	0.03	0.28	0.42	0.83	-0.05	0.53	0.22	-0.47	0.06	-0.03	-0.15	0.5	0.11	0.03	0.26	0.22	0.2	0.48

Click cells to compare fundamentals

AllovirInc Account Relationship Matchups

AllovirInc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	139.4M	370.8M	286.6M	277.1M	190.8M	236.5M
Other Current Liab	5.4M	8.1M	22.9M	14.2M	10.8M	11.4M
Total Current Liabilities	9.1M	12.3M	37.9M	24.3M	28.4M	21.2M
Total Stockholder Equity	(51.5M)	353.1M	225.3M	224.5M	145.8M	158.9M
Net Tangible Assets	(51.5M)	353.1M	225.3M	224.5M	258.2M	158.6M
Net Debt	(49.3M)	(114.0M)	(171.6M)	(70.7M)	(62.7M)	(65.8M)
Retained Earnings	(55.3M)	(125.1M)	(297.1M)	(465.8M)	(656.2M)	(623.4M)
Accounts Payable	630K	963K	8.4M	3.0M	6.8M	3.6M
Cash	61.1M	122.7M	201.7M	106.1M	90.1M	110.7M
Non Current Assets Total	12.1M	9.5M	33.2M	34.0M	3.2M	3.0M
Cash And Short Term Investments	126.1M	356.3M	248.1M	233.8M	183.9M	214.6M
Net Receivables	560K	450K	50K	157K	206K	230K
Common Stock Shares Outstanding	65.1M	26.9M	62.8M	76.7M	104.1M	68.3M
Short Term Investments	65.0M	233.7M	46.5M	127.7M	93.8M	103.9M
Liabilities And Stockholders Equity	139.4M	370.8M	286.6M	277.1M	190.8M	236.5M
Non Current Liabilities Total	181.8M	5.5M	23.5M	28.2M	16.6M	15.8M
Capital Lease Obligations	11.8M	8.7M	30.1M	35.4M	27.4M	20.8M
Other Current Assets	676K	5.0M	5.2M	9.3M	3.5M	4.3M
Other Stockholder Equity	(169.4M)	107.5M	522.5M	690.8M	802.0M	842.1M
Total Liab	190.9M	17.8M	61.3M	52.6M	45.0M	56.5M
Net Invested Capital	(51.5M)	353.1M	225.3M	224.5M	145.8M	158.9M
Total Current Assets	127.3M	361.3M	253.3M	243.1M	187.6M	219.6M
Net Working Capital	118.2M	349.0M	215.5M	218.7M	159.3M	198.4M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether AllovirInc is a strong investment it is important to analyze AllovirInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AllovirInc's future performance. For an informed investment choice regarding AllovirInc Stock, refer to the following important reports:

How To Invest In AllovirInc

Details

Is AllovirInc Stock a good investment?

Details

What is AllovirInc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AllovirInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.

You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for AllovirInc Stock analysis

When running AllovirInc's price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.

	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	CEOs Directory Screen CEOs from public companies around the world
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format

Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.65)

Return On Assets

(0.52)

Return On Equity

(1.14)

The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if AllovirInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AllovirInc Common Stock Shares Outstanding vs Net Receivables Analysis

Common Stock Shares Outstanding vs Net Receivables

Common Stock Shares Outstanding vs Net Receivables Correlation Analysis

Correlation Coefficient

Common Stock Shares Outstanding

Net Receivables

AllovirInc fundamental ratios Correlations

AllovirInc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AllovirInc fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for AllovirInc Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Total Current Assets

Other Stockholder Equity	- 0.98	Retained Earnings
Cash	- 0.98	Net Debt
Inventory	- 0.92	Cash And Short Term Investments
Inventory	- 0.92	Total Assets
Total Current Assets	- 0.91	Inventory
Net Debt	- 0.91	Other Current Liab